Has Tammy Baldwin taken steps to lower prescription drug prices?
U.S. Sen. Tammy Baldwin, D-Wisconsin, has backed efforts to reduce prescription drug prices:
Cosponsored 2024 legislation to cap annual out-of-pocket costs at $2,000 per individual and $4,000 per family for people with private health insurance. No action has been taken.
Sent letters in January 2024 along with other senators to drug manufacturers demanding information on “exorbitant” asthma inhalers prices.
Sponsored 2023 legislation to require drug manufacturers to provide details of and justification for certain price increases. No action has been taken.
Supported the Inflation Reduction Act, which became law in 2022. It requires Medicare to negotiate the price of certain drugs.
Baldwin’s challenger in the Nov. 5, 2024, election, Republican Eric Hovde, stated that Baldwin "always talks about, 'I'm going to lower drug prices.' She's done nothing on that."
Average U.S. prescription drug prices are 2.78 times higher than in 33 other nations, the RAND think tank reported in February.